Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 10, 2014Clinical Science

Atrial natriuretic peptide gene variants and circulating levels: implications in cardiovascular diseases

View Full Paper
Ask AI
Bookmark
Share

Design

Review

Authors

SRSperanza RubattuIstituto Neurologico MediterraneoSSSebastiano SciarrettaHeart Failure & Transplant
Massimo Volpe
Massimo VolpePreventive Cardiology

Discussion

Loading...

Member takes

Implication

ANP variants may refine CV risk stratification in carriers; leaves open prospective validation before any clinical adoption.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Rubattu et al. (2014) studied this question.

synapsesocial.com/papers/6a716ee02163a0a01bc5936dhttps://doi.org/10.1042/cs20130427
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Natriuretic Peptides: An Update on Bioactivity, Potential Therapeutic Use, and Implication in Cardiovascular Diseases2008 · 196 citations
  2. 2C2238 Atrial Natriuretic Peptide Molecular Variant Is Associated With Endothelial Damage and Dysfunction Through Natriuretic Peptide Receptor C Signaling2013 · 35 citations
  3. 3Reactive oxygen species-mediated effects on vascular remodeling induced by human atrial natriuretic peptide T2238C molecular variant in endothelial cells in vitro2009 · 24 citations
  4. 4Natriuretic peptide Val7Met substitution and risk of coronary artery disease in Greek patients with familial hypercholesterolemia2006 · 11 citations
  5. 5Differential brain atrial natriuretic peptide expression co-segregates with occurrence of early stroke in the stroke-prone phenotype of the spontaneously hypertensive rat1999 · 21 citations